Highlights included a 32.2% year in year increase in total revenue to a record high of $100.8 million. And with net profits ...
One of two of Opthea's phase III trials for a common eye disease has failed to meet its objectives, casting doubts on the ...
James Hardie shares sink after $14b deal to acquire American giant As the building material group’s shares plunged, chief executive Aaron Erter rejected concerns it had overpaid in its deal to buy the ...
Bioxyne's latest capital raise has proved fruitful, filling the company's coffers ahead of its push into European markets. ..
Despite many ASX retailers doing it tough lately, there's still compelling investing opportunities to be found in this sector ...
Investors are bidding up the Mineral Resources share price on Monday. Is this why? The post Why is the Mineral Resources share price racing ahead of the ASX 200 on Monday? appeared first on The Motley ...